Chemed Statistics
Total Valuation
Chemed has a market cap or net worth of $6.94 billion. The enterprise value is $7.29 billion.
| Market Cap | 6.94B |
| Enterprise Value | 7.29B |
Important Dates
The last earnings date was Tuesday, October 27, 2026, after market close.
| Earnings Date | Oct 27, 2026 |
| Ex-Dividend Date | Aug 17, 2026 |
Share Statistics
Chemed has 13.02 million shares outstanding. The number of shares has decreased by -8.29% in one year.
| Current Share Class | 13.02M |
| Shares Outstanding | 13.02M |
| Shares Change (YoY) | -8.29% |
| Shares Change (QoQ) | -0.48% |
| Owned by Insiders (%) | 1.47% |
| Owned by Institutions (%) | 98.88% |
| Float | 11.85M |
Valuation Ratios
The trailing PE ratio is 25.48 and the forward PE ratio is 19.74. Chemed's PEG ratio is 1.80.
| PE Ratio | 25.48 |
| Forward PE | 19.74 |
| PS Ratio | 2.70 |
| Forward PS | 2.41 |
| PB Ratio | 8.09 |
| P/TBV Ratio | 249.06 |
| P/FCF Ratio | 23.50 |
| P/OCF Ratio | 19.12 |
| PEG Ratio | 1.80 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 24.66 |
Financial Position
The company has a current ratio of 1.11, with a Debt / Equity ratio of 0.46.
| Current Ratio | 1.11 |
| Quick Ratio | 0.92 |
| Debt / Equity | 0.46 |
| Debt / EBITDA | 0.77 |
| Debt / FCF | 1.33 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 29.14% and return on invested capital (ROIC) is 24.07%.
| Return on Equity (ROE) | 29.14% |
| Return on Assets (ROA) | 14.08% |
| Return on Invested Capital (ROIC) | 24.07% |
| Return on Capital Employed (ROCE) | n/a |
| Weighted Average Cost of Capital (WACC) | 6.68% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | 15,811 |
| Asset Turnover | 1.59 |
| Inventory Turnover | 221.26 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | 26.13% |
Stock Price Statistics
The stock price has increased by +22.11% in the last 52 weeks. The beta is 0.51, so Chemed's price volatility has been lower than the market average.
| Beta (5Y) | 0.51 |
| 52-Week Price Change | +22.11% |
| 50-Day Moving Average | 514.62 |
| 200-Day Moving Average | 461.88 |
| Relative Strength Index (RSI) | 63.78 |
| Average Volume (20 Days) | 144,041 |
Short Selling Information
The latest short interest is 596,751, so 4.59% of the outstanding shares have been sold short.
| Short Interest | 596,751 |
| Short Previous Month | 564,624 |
| Short % of Shares Out | 4.59% |
| Short % of Float | 5.04% |
| Short Ratio (days to cover) | 3.97 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | n/a |
| Pretax Income | n/a |
| Net Income | n/a |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | $20.93 |
Balance Sheet
The company has $48.43 million in cash and $392.19 million in debt, with a net cash position of -$343.77 million or -$26.41 per share.
| Cash & Cash Equivalents | 48.43M |
| Total Debt | 392.19M |
| Net Cash | -343.77M |
| Net Cash Per Share | -$26.41 |
| Equity (Book Value) | 861.42M |
| Book Value Per Share | 65.97 |
| Working Capital | 34.79M |
Cash Flow
In the last 12 months, operating cash flow was $363.16 million and capital expenditures -$67.70 million, giving a free cash flow of $295.45 million.
| Operating Cash Flow | 363.16M |
| Capital Expenditures | -67.70M |
| Depreciation & Amortization | 63.29M |
| Net Borrowing | 253.18M |
| Free Cash Flow | 295.45M |
| FCF Per Share | $22.70 |
Margins
| Gross Margin | 33.54% |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | 10.61% |
| EBITDA Margin | 16.53% |
| EBIT Margin | 14.15% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $2.80, which amounts to a dividend yield of 0.53%.
| Dividend Per Share | $2.80 |
| Dividend Yield | 0.53% |
| Dividend Growth (YoY) | 19.05% |
| Years of Dividend Growth | 17 |
| Payout Ratio | 11.94% |
| FCF Payout Ratio | 11.01% |
| Buyback Yield | 8.29% |
| Shareholder Yield | 8.82% |
| Earnings Yield | 3.92% |
| FCF Yield | 4.26% |
Analyst Forecast
The average price target for Chemed is $605.00, which is 13.43% higher than the current price. The consensus rating is "Buy".
| Price Target | $605.00 |
| Price Target Difference | 13.43% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 6.57% |
| EPS Growth Forecast (3Y) | 11.95% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on May 12, 2005. It was a forward split with a ratio of 2:1.
| Last Split Date | May 12, 2005 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Chemed has an Altman Z-Score of 9.15 and a Piotroski F-Score of 3.
| Altman Z-Score | 9.15 |
| Piotroski F-Score | 3 |